4
Changes in Ownership
ANAPTYSBIO, INC Filed Acc 0001209191-18-025382
Director sold 33,000 shares at an average $86.88 ($2,866,913)
From the SEC's structured data for this filing
Trades in this filing
Lydon Nicholas · Director
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-04-16 | Sale : show line 1 in the form | −2,600 | $84.18 | $218,880 | 301,506 | D |
| 2018-04-16 | Sale : show line 2 in the form | −10,310 | $85.11 | $877,491 | 291,196 | D |
| 2018-04-16 | Sale : show line 3 in the form | −1,390 | $86.15 | $119,753 | 289,806 | D |
| 2018-04-16 | Sale : show line 4 in the form | −9,425 | $87.46 | $824,341 | 280,381 | D |
| 2018-04-16 | Sale : show line 5 in the form | −4,250 | $88.30 | $375,267 | 276,131 | D |
| 2018-04-16 | Sale : show line 6 in the form | −2,803 | $89.42 | $250,631 | 273,328 | D |
| 2018-04-16 | Sale : show line 7 in the form | −2,222 | $90.26 | $200,549 | 271,106 | D |
| Open-market sales · 33,000 sh · avg $86.88 · $2,866,913 | ||||||
Loading xslF345X03/doc4.xml…